SG11201600218SA - Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel - Google Patents
Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrelInfo
- Publication number
- SG11201600218SA SG11201600218SA SG11201600218SA SG11201600218SA SG11201600218SA SG 11201600218S A SG11201600218S A SG 11201600218SA SG 11201600218S A SG11201600218S A SG 11201600218SA SG 11201600218S A SG11201600218S A SG 11201600218SA SG 11201600218S A SG11201600218S A SG 11201600218SA
- Authority
- SG
- Singapore
- Prior art keywords
- clopidogrel
- acetylsalicylic acid
- pharmaceutical tablet
- tablet
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/FR2013/051874 WO2015015062A1 (fr) | 2013-08-02 | 2013-08-02 | Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel |
| PCT/EP2014/066110 WO2015014766A1 (en) | 2013-08-02 | 2014-07-25 | Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201600218SA true SG11201600218SA (en) | 2016-02-26 |
Family
ID=49085055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201600218SA SG11201600218SA (en) | 2013-08-02 | 2014-07-25 | Pharmaceutical tablet comprising acetylsalicylic acid and clopidogrel |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP3027176B1 (es) |
| JP (1) | JP5905165B2 (es) |
| KR (1) | KR102243349B1 (es) |
| CN (1) | CN105407877B (es) |
| AR (1) | AR097193A1 (es) |
| BR (1) | BR112016001822B1 (es) |
| CL (1) | CL2016000143A1 (es) |
| CR (1) | CR20160067A (es) |
| DO (1) | DOP2016000024A (es) |
| ES (1) | ES2648913T3 (es) |
| HK (1) | HK1221649A1 (es) |
| MY (1) | MY176793A (es) |
| PE (1) | PE20160212A1 (es) |
| PH (1) | PH12016500121B1 (es) |
| SG (1) | SG11201600218SA (es) |
| TW (1) | TWI642435B (es) |
| WO (2) | WO2015015062A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104800183B (zh) * | 2015-04-14 | 2016-08-31 | 陕西必康制药集团控股有限公司 | 一种阿司匹林肠溶片及其制备方法和应用 |
| CN108289849A (zh) * | 2015-06-26 | 2018-07-17 | 韩国联合制药株式会社 | 莫沙必利与雷贝拉唑的复合制剂 |
| WO2017037741A1 (en) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Compact solid dosage form of aspirin and clopidogrel |
| CN107308157B (zh) * | 2017-06-08 | 2020-02-21 | 广州白云山天心制药股份有限公司 | 一种含有氯吡格雷的复方口服固体制剂及其制备方法 |
| WO2019030610A1 (en) * | 2017-08-11 | 2019-02-14 | Solutions In Innovative Research Pvt. Ltd. | PHARMACEUTICAL COMPOSITIONS WITH DUAL DIRECTLY COMPRESSIBLE MEDICAMENT RELEASE |
| CN107669690A (zh) * | 2017-10-23 | 2018-02-09 | 罗铭炽 | 一种含阿司匹林和氯吡格雷的片剂 |
| CN107693524A (zh) * | 2017-10-23 | 2018-02-16 | 罗铭炽 | 一种含阿司匹林和氯吡格雷的制备方法 |
| CN109528668A (zh) * | 2018-12-20 | 2019-03-29 | 华中药业股份有限公司 | 阿司匹林片及其制备方法 |
| CN112587495A (zh) * | 2020-12-14 | 2021-04-02 | 乐普药业股份有限公司 | 一种阿司匹林和硫酸氢氯吡格雷复方制剂及其制备方法 |
| EP4091605A1 (en) | 2021-05-19 | 2022-11-23 | G.L. Pharma GmbH | Pharmaceutical tablet comprising acetylsalicylic acid |
| CN115212180B (zh) * | 2022-09-03 | 2024-05-10 | 深圳市信宜特科技有限公司 | 一种阿司匹林和硫酸氢氯吡格雷的复方制剂及其制备方法 |
| KR20240050841A (ko) * | 2022-10-12 | 2024-04-19 | 일양약품주식회사 | 클로피도그렐 및 일라프라졸을 포함하는 복합제제 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04346930A (ja) * | 1991-05-25 | 1992-12-02 | Sumitomo Pharmaceut Co Ltd | 安定なアスピリン腸溶錠 |
| FR2744918B1 (fr) | 1996-02-19 | 1998-05-07 | Sanofi Sa | Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique |
| FR2779726B1 (fr) | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
| FR2792836B3 (fr) * | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
| CN101703513B (zh) * | 2009-11-10 | 2014-04-23 | 沈阳药科大学 | 阿司匹林和氯吡格雷或其药学上可接受的盐的复方缓释制剂 |
| CA2792232C (en) * | 2010-03-11 | 2014-07-15 | Wockhardt Limited | A device for the manufacture of a dosage form with a hole and method of manufacture |
| CN101874786B (zh) * | 2010-06-05 | 2012-04-25 | 浙江金华康恩贝生物制药有限公司 | 无溶剂挤出滚圆法制备阿司匹林肠溶制剂 |
| KR20120068277A (ko) * | 2010-12-17 | 2012-06-27 | 한미사이언스 주식회사 | ＨＭＧ－ＣｏＡ 환원효소 억제제 및 아스피린을 포함하는 약제학적 복합제제 |
| EP2755641A4 (en) * | 2011-09-14 | 2015-03-18 | Pozen Inc | CONTROLLED DOSAGE OF CLOPIDOGREL IN MAGIC ACID INHIBITION THERAPIES |
| KR101675501B1 (ko) * | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | 클로피도그렐 및 아스피린의 복합제제 |
| KR101473268B1 (ko) * | 2012-03-09 | 2014-12-16 | 주식회사유한양행 | 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법 |
-
2013
- 2013-08-02 JP JP2015529093A patent/JP5905165B2/ja active Active
- 2013-08-02 WO PCT/FR2013/051874 patent/WO2015015062A1/fr active Application Filing
-
2014
- 2014-07-25 BR BR112016001822-2A patent/BR112016001822B1/pt active IP Right Grant
- 2014-07-25 PE PE2016000120A patent/PE20160212A1/es unknown
- 2014-07-25 WO PCT/EP2014/066110 patent/WO2015014766A1/en active Application Filing
- 2014-07-25 SG SG11201600218SA patent/SG11201600218SA/en unknown
- 2014-07-25 KR KR1020167004776A patent/KR102243349B1/ko active IP Right Grant
- 2014-07-25 MY MYPI2016700042A patent/MY176793A/en unknown
- 2014-07-25 CN CN201480042849.3A patent/CN105407877B/zh active Active
- 2014-07-25 EP EP14753025.7A patent/EP3027176B1/en active Active
- 2014-07-25 ES ES14753025.7T patent/ES2648913T3/es active Active
- 2014-08-01 AR ARP140102898A patent/AR097193A1/es unknown
- 2014-08-01 TW TW103126491A patent/TWI642435B/zh active
-
2016
- 2016-01-19 PH PH12016500121A patent/PH12016500121B1/en unknown
- 2016-01-19 DO DO2016000024A patent/DOP2016000024A/es unknown
- 2016-01-20 CL CL2016000143A patent/CL2016000143A1/es unknown
- 2016-02-09 CR CR20160067A patent/CR20160067A/es unknown
- 2016-08-17 HK HK16109836.1A patent/HK1221649A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102243349B1 (ko) | 2021-04-21 |
| PE20160212A1 (es) | 2016-05-09 |
| ES2648913T3 (es) | 2018-01-08 |
| CL2016000143A1 (es) | 2016-06-24 |
| CN105407877B (zh) | 2019-05-07 |
| CR20160067A (es) | 2016-04-01 |
| TW201601721A (zh) | 2016-01-16 |
| KR20160037967A (ko) | 2016-04-06 |
| HK1221649A1 (zh) | 2017-06-09 |
| DOP2016000024A (es) | 2016-03-30 |
| AR097193A1 (es) | 2016-02-24 |
| JP2015526498A (ja) | 2015-09-10 |
| PH12016500121A1 (en) | 2016-04-25 |
| EP3027176A1 (en) | 2016-06-08 |
| MY176793A (en) | 2020-08-21 |
| BR112016001822B1 (pt) | 2022-10-18 |
| PH12016500121B1 (en) | 2016-04-25 |
| BR112016001822A2 (pt) | 2017-08-01 |
| EP3027176B1 (en) | 2017-08-23 |
| WO2015014766A1 (en) | 2015-02-05 |
| WO2015015062A1 (fr) | 2015-02-05 |
| CN105407877A (zh) | 2016-03-16 |
| JP5905165B2 (ja) | 2016-04-20 |
| TWI642435B (zh) | 2018-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1221649A1 (zh) | 包含乙酰水楊酸和氯吡格雷的藥物片劑 | |
| EP2945623A4 (en) | SIGNALHEMMER OF THE HEDGEHOG SIGNALING PATH AND THERAPEUTIC APPLICATIONS THEREOF | |
| EP2972767A4 (en) | DEVICE FOR STORING AND DISPOSING MEDICAMENTS | |
| ZA201507576B (en) | Pharmaceutical combination drug | |
| PL3060203T3 (pl) | Tabletka musująca zawierająca wysoki poziom aspiryny | |
| HK1219691A1 (zh) | 醫藥組成物及其用途 | |
| SG11201509194SA (en) | Radiomitigating pharmaceutical formulations | |
| HK1223833A1 (zh) | 藥物劑型 | |
| HK1205463A1 (zh) | 含有 -羥基- -咪唑- -甲酰胺的片劑 | |
| EP2987489A4 (en) | MEDICINAL FORMULATION WITH DELAYED RELEASE | |
| PT3046548T (pt) | Comprimido compreendendo crospovidona | |
| GB201600342D0 (en) | Chewable tablet | |
| HUP1600414A2 (hu) | Bisoprololt és ramiprilt tartalmazó stabil kombinációs gyógyszerkészítmény | |
| IL240447A (en) | Propionic Acid-Baryl Acid Derivatives and Their Use as Pharmaceutical Preparations | |
| GB201316761D0 (en) | Jewellery Display and Storage | |
| EP3055286A4 (en) | 4-methylsulfonyl-2-butenenitrile and its pharmaceutical use | |
| TH1601000441A (th) | ยาเม็ดแบนทางเภสัชกรรมซึ่งประกอบรวมด้วยอะเซทิลซาลิคไซลิคแอซิดและ โคลพิโดเกรล | |
| SG11201506190QA (en) | Biaryl-propionic acid derivatives and their use as pharmaceuticals | |
| GB201316498D0 (en) | Topical Pharmaceutical formulation | |
| GB201312277D0 (en) | Head mounted display and tablet |